The Upcoming Cannabis Rescheduling in the US and Its Broad Industry Effects
Industry players who capitalize on regulatory changes may achieve substantial international growth. The global cannabis industry is on the brink of a transformative shift, driven by significant regulatory developments in the United States and Europe. The Biden administration’s proposal to reschedule cannabis from Schedule I to Schedule III of the Controlled Substances Act (CSA) could dramatically reshape the...